이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Archit Organosys 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kandarp Amin

최고 경영자

₹7.8m

총 보상

CEO 급여 비율	100.0%
CEO 임기	24.5yrs
CEO 소유권	34.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.4yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Kandarp Amin 의 보수는 Archit Organosys 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	₹33m
Dec 31 2023	n/a	n/a	₹34m
Sep 30 2023	n/a	n/a	₹61m
Jun 30 2023	n/a	n/a	₹88m
Mar 31 2023	₹8m	₹8m	₹113m
Dec 31 2022	n/a	n/a	₹113m
Sep 30 2022	n/a	n/a	₹111m
Jun 30 2022	n/a	n/a	₹94m
Mar 31 2022	₹8m	₹8m	₹82m
Dec 31 2021	n/a	n/a	₹79m
Sep 30 2021	n/a	n/a	₹74m
Jun 30 2021	n/a	n/a	₹71m
Mar 31 2021	₹8m	₹8m	₹50m
Dec 31 2020	n/a	n/a	₹29m
Sep 30 2020	n/a	n/a	₹8m
Jun 30 2020	n/a	n/a	-₹8m
Mar 31 2020	₹8m	₹8m	-₹8m
Dec 31 2019	n/a	n/a	₹497k
Sep 30 2019	n/a	n/a	-₹19m
Jun 30 2019	n/a	n/a	-₹25m
Mar 31 2019	₹6m	₹6m	-₹47m
Dec 31 2018	n/a	n/a	-₹41m
Sep 30 2018	n/a	n/a	-₹10m
Jun 30 2018	n/a	n/a	₹11m
Mar 31 2018	₹5m	₹5m	₹5m

보상 대 시장: Kandarp 의 총 보상 ($USD 93.46K )은 Indian 시장( $USD 38.49K ).

보상과 수익: Kandarp 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Kandarp Amin (67 yo)

24.5yrs

테뉴어

₹7,800,000

보상

Mr. Kandarp Krishnakant Amin serves as Chairman of Archit Organosys Limited and has been its Whole-Time Director since January 22, 2000. He joined Archit Organosys Limited since January 22, 2000. He has ex...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kandarp Amin	Chairman	24.5yrs	₹7.80m	34.15% ₹ 357.7m
Archana Amin	Whole-Time Director	24.8yrs	₹7.20m	22.19% ₹ 232.4m
Archit Amin	Whole Time Director	7.2yrs	₹5.70m	8.3% ₹ 87.0m
Nikul Patel	Independent Non-Executive Director	2.9yrs	데이터 없음	0.000010% ₹ 104.7
Shreeraj Desai	Independent Non-Executive Director	4.4yrs	데이터 없음	데이터 없음
Vatsal Vora	Additional Independent Director	1.1yrs	데이터 없음	데이터 없음
Bhavin Shah	Additional Independent Director	1.1yrs	데이터 없음	0.074% ₹ 773.3k

4.4yrs

평균 재임 기간

41yo

평균 연령

경험이 풍부한 이사회: 524640 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.

Archit Organosys 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Archit Organosys Limited Announces Chief Financial Officer Changes

Recent updates

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Investor sentiment improves as stock rises 25%

Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023)

New major risk - Market cap size

Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 18%

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Now 20% undervalued after recent price drop

New major risk - Market cap size

Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023)

New minor risk - Profit margin trend

Archit Organosys Limited Declares Dividend

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024

Upcoming dividend of ₹0.50 per share at 1.0% yield

Archit Organosys Limited Proposes Declare

Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₹0.50 per share at 0.9% yield

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Investor sentiment deteriorated over the past week

Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022)

Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022

Archit Organosys Limited Announces Chief Financial Officer Changes

Investor sentiment improved over the past week

Archit Organosys Limited Approves Dividend

Investor sentiment improved over the past week

Archit Organosys Limited, Annual General Meeting, Sep 08, 2022

First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022)

Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022

Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer

Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021)

Independent Director Rajendraprasad Shah has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹1.02 (vs ₹0.37 loss in 3Q 2020)

Archit Organosys Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹25.00

New 90-day high: ₹24.55

Investor sentiment deteriorated over the past week

New 90-day high: ₹23.80

Archit Organosys Limited to Report First Half, 2021 Results on Nov 09, 2020

New 90-day high: ₹14.60

Archit Organosys Limited announced that it expects to receive INR 13.75 million in funding

First quarter earnings released

Full year earnings released - ₹0.53 loss per share

New 90-day high - ₹10.56

Full year earnings released - ₹0.53 loss per share

CEO 보상 분석